Abbott's Ultane Patent Declared Invalid
An appeals court panel has invalidated an Abbott Laboratories Inc. patent covering Ultane, thus solidifying rival pharmaceutical company Baxter International Inc.'s ability to sell a generic version of the popular inhaled...To view the full article, register now.
Already a subscriber? Click here to view full article